Company overview
Basic information
Company name
Horseshow NO, VšĮ
Company code
307193067
Registered address
Vilnius, Žirmūnų g. 57-50, LT-09110
Registration date
2025-06-06
Company age: 1 y. 4 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Public Institution
NACE activity
Other sports activities n.e.c.
Sector
Namų ūkiams paslaugas teikiančios ne pelno institucijos
Ownership form
Private without foreign capital
VšĮ Horseshow NO
Company code: 307193067
Address: Vilnius, Žirmūnų g. 57-50, LT-09110
Description
This description was generated by artificial intelligence.
Horseshow NO, VšI (company code 307193067) is an operational public institution registered on 6 June 2025. It operates as a private legal entity under the legal form of a Public Institution and is classified in the sector of non-profit institutions providing services to households. The company is privately owned, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital, and its governance is described as CEO only. It is a micro-sized entity based in Vilnius, Žirmunu g. 57-50, Vilniaus m. sav., Vilniaus apskr. The company’s registered activity is EVRK S.93.19.90, Other sports activities n.e.c. For 2025, reported financial results cover 208 days and show revenue of EUR 14.4K and net profit of EUR 1.2K, with a profit margin of 8.2%. The available financial snapshot indicates a small-scale business with positive profitability in its latest reported financial year. Staff figures are not provided in the available data, including so far in 2026.
Download a detailed company report
Make confident decisions with all the information about Horseshow NO, VšĮ. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.